New Dual-Mapping Tech Reads Gene Activity and Chromatin State Across Intact Tissue
Yale researchers unveil two spatial sequencing methods that simultaneously map gene expression and epigenomic state within intact tissue sections at near single-cell resolution.
Summary
Scientists at Yale have developed two powerful spatial genomics protocols—spatial-ATAC-RNA-seq and spatial-CUT&Tag-RNA-seq—that simultaneously capture gene expression and epigenomic information from intact tissue sections. Previously, researchers had to choose between studying transcriptomics or epigenomics separately, losing the interplay between these layers. These new methods use microfluidic barcoding to create a two-dimensional pixel map of tissue at near single-cell resolution, enabling researchers to see how chromatin accessibility or histone modifications align with active gene programs across different tissue regions. Libraries can be generated in 3–5 days. This multimodal spatial approach promises deeper insight into how cell identity is established and maintained across tissues—directly relevant to aging, cancer, and disease research.
Detailed Summary
Understanding how gene regulation is organized across tissue space is a fundamental challenge in biology and medicine. The epigenome—comprising chromatin accessibility and histone modifications—directly controls which genes are expressed in which cells. Disruptions to this regulatory landscape underlie aging, neurodegeneration, and cancer. Until now, spatial genomics tools largely captured only one molecular layer at a time, limiting the ability to connect regulatory state with transcriptional output in a tissue context.
Researchers at Yale University have developed two complementary protocols—spatial-ATAC-RNA-seq and spatial-CUT&Tag-RNA-seq—that jointly profile the transcriptome and epigenome genome-wide while preserving the spatial organization of tissue. Both methods begin with tissue fixation, permeabilization, and in situ reverse transcription to capture RNA. Spatial-ATAC-RNA-seq then uses Tn5 transposase to identify regions of open, accessible chromatin. Spatial-CUT&Tag-RNA-seq instead uses antibodies targeting specific histone modifications, followed by Protein A-fused Tn5 tagmentation to mark those regions.
A key innovation is the use of a microfluidic device that delivers two orthogonal sets of oligonucleotide barcodes across the tissue, creating a mosaic of spatially indexed pixels at near single-cell resolution. This allows each captured molecule—whether RNA or chromatin fragment—to be assigned a precise physical location within the tissue section.
The resulting multimodal data enables simultaneous mapping of transcriptomic and epigenomic landscapes, offering unprecedented insight into tissue heterogeneity, cell-type-specific regulatory programs, and spatially organized gene regulation. This is particularly relevant to aging research, where epigenomic drift and altered chromatin states are hallmarks of cellular senescence and tissue dysfunction.
As a protocols paper, the study presents detailed procedural guidance rather than new biological discoveries. The full power of these methods will depend on computational integration pipelines and their application to disease and aging tissue models.
Key Findings
- Two new protocols co-profile transcriptome and epigenome genome-wide within intact tissue at near single-cell spatial resolution.
- Spatial-ATAC-RNA-seq maps chromatin accessibility alongside gene expression using Tn5 transposase.
- Spatial-CUT&Tag-RNA-seq profiles histone modifications and transcription simultaneously via antibody-guided tagmentation.
- Microfluidic barcoding creates a 2D spatial pixel map linking molecular data to tissue location.
- Full sequencing libraries can be generated in 3–5 days, making the workflow practical for broad research use.
Methodology
This is a detailed protocols paper describing two spatial multi-omics methods developed at Yale. Both rely on microfluidic barcoding of intact tissue sections, combining in situ reverse transcription for RNA capture with either ATAC-seq or CUT&Tag for epigenomic profiling. The paper provides step-by-step procedural guidance rather than reporting results from a new biological study.
Study Limitations
Only the abstract is available; specific performance benchmarks, tissue types validated, and sensitivity comparisons are not assessable. As a methodology paper, translational findings depend on future biological applications. Computational demands for integrating dual-modality spatial data may limit accessibility for some research groups.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.